These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35439694)

  • 1. A study on biorelevant calciprotein particles: Effect of stabilizing agents on the formation and crystallization mechanisms.
    Gelli R; Pucci V; Ridi F; Baglioni P
    J Colloid Interface Sci; 2022 Aug; 620():431-441. PubMed ID: 35439694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconsidering the role of albumin towards amorphous calcium phosphate-based calciprotein particles formation and stability from a physico-chemical perspective.
    Gelli R; Ridi F
    Colloids Surf B Biointerfaces; 2023 Jul; 227():113372. PubMed ID: 37257300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification.
    Ter Braake AD; Eelderink C; Zeper LW; Pasch A; Bakker SJL; de Borst MH; Hoenderop JGJ; de Baaij JHF
    Nephrol Dial Transplant; 2020 May; 35(5):765-773. PubMed ID: 31605492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
    Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
    Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease.
    Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles.
    Heiss A; Eckert T; Aretz A; Richtering W; van Dorp W; Schäfer C; Jahnen-Dechent W
    J Biol Chem; 2008 May; 283(21):14815-25. PubMed ID: 18364352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel assessments of systemic calcification propensity.
    Pasch A
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):278-84. PubMed ID: 27228365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifying the crystallization of amorphous magnesium-calcium phosphate nanoparticles with proteins from Moringa oleifera seeds.
    Gelli R; Tonelli M; Ridi F; Bonini M; Kwaambwa HM; Rennie AR; Baglioni P
    J Colloid Interface Sci; 2021 May; 589():367-377. PubMed ID: 33476891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity.
    Köppert S; Büscher A; Babler A; Ghallab A; Buhl EM; Latz E; Hengstler JG; Smith ER; Jahnen-Dechent W
    Front Immunol; 2018; 9():1991. PubMed ID: 30233585
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.
    Miura Y; Kurosu H; Kuro-O M
    Methods Mol Biol; 2023; 2664():333-341. PubMed ID: 37423998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.
    Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA
    Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
    Kuro-O M
    Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):344-351. PubMed ID: 37074676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetuin-A function in systemic mineral metabolism.
    Herrmann M; Kinkeldey A; Jahnen-Dechent W
    Trends Cardiovasc Med; 2012 Nov; 22(8):197-201. PubMed ID: 22902178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between amorphous calcium-phosphate ratios in circulating calciprotein particles and prognostic biomarkers in hemodialysis patients.
    Nakamura K; Isoyama N; Nakayama Y; Hiroyoshi T; Fujikawa K; Miura Y; Kurosu H; Matsuyama H; Kuro-O M
    Sci Rep; 2022 Jul; 12(1):13030. PubMed ID: 35906396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on Fetuin-A controlled calcification inhibition.
    Heiss A; Pipich V; Jahnen-Dechent W; Schwahn D
    Biophys J; 2010 Dec; 99(12):3986-95. PubMed ID: 21156141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.
    Thiem U; Hewitson TD; Toussaint ND; Holt SG; Haller MC; Pasch A; Cejka D; Smith ER
    Nephrol Dial Transplant; 2023 May; 38(5):1282-1296. PubMed ID: 36107466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A shielding topology stabilizes the early stage protein-mineral complexes of fetuin-A and calcium phosphate: a time-resolved small-angle X-ray study.
    Rochette CN; Rosenfeldt S; Heiss A; Narayanan T; Ballauff M; Jahnen-Dechent W
    Chembiochem; 2009 Mar; 10(4):735-40. PubMed ID: 19222044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial.
    Bressendorff I; Hansen D; Pasch A; Holt SG; Schou M; Brandi L; Smith ER
    Nephrol Dial Transplant; 2021 Mar; 36(4):713-721. PubMed ID: 31764984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated calciprotein crystallization time (T50) is correlated with impaired lung diffusion capacity in systemic sclerosis.
    Geroldinger-Simic M; Sohail A; Razazian M; Krennmayr B; Pernsteiner V; Putz T; Lackner HK; Pasch A; Sepp N; Alesutan I; Voelkl J
    Front Immunol; 2024; 15():1425885. PubMed ID: 39399492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.